Lite Strategy, Inc. — Director's Dealing 2018

Sep 7, 2018

SEC Form 4/A — Form 4/A

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2018-08-06

Reporting Person: GOLD DANIEL P PHD (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-06	Common Stock	F	50938	$3.75	Disposed	322882	Direct

Footnotes

F1: Represents the number of shares withheld by and surrendered to the Issuer on August 6, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018. The number of shares withheld by and surrendered to the Issuer was incorrectly reported as 54,093 in the original filing of the Form 4 to which this amendment relates. Such number of shares withheld was overstated by 3,155 shares.

F2: The number of shares beneficially owned was incorrectly understated by 3,155 shares in the original filing of the Form 4 to which this amendment relates as a result of the incorrect reporting of the number of shares withheld described in Note 1 above.